No Data
No Data
No Data
No Data
No Data
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases
GlobeNewswireApr 25 08:00 ET
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
PDF Version SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or r
Unity BiotechnologyApr 23 20:00 ET
Unity Biotechnology Adds More Patients, Extends Length of Trial of Prospective Macular Edema Treatment
Unity Biotechnology (UBX) early Tuesday said phase 2b testing of its UBX1325 drug candidate has been extended by an extra 12 weeks allowing researchers to compare the drug's durability with aflibercep
MT NewswiresApr 23 10:37 ET
Express News | UNITY Biotechnology : Believe That Current Cash, Cash Equivalents and Marketable Securities Are Sufficient to Fund Operations Into Q3 of 2025
Moomoo 24/7Apr 23 08:03 ET
Express News | UNITY Biotechnology Announces Extension Of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 For Patients In Diabetic Macular Edema
Moomoo 24/7Apr 23 08:02 ET
Express News | UNITY Biotechnology Inc: Expects to Disclose Topline Results From Aspire Study in Two Data Readouts: 24-Week Primary Endpoint Data in Q1 of 2025
Moomoo 24/7Apr 23 08:02 ET
BullRunner : You think it's going to pop eventually?
AlvinnnnnnngeniusOP BullRunner: The news is bad don’t risk it
BullRunner AlvinnnnnnngeniusOP: You see what's going on with$Alibaba (BABA.US)$ ?
No Data
No Data